Press Releases
-
MAUNA KEA TECHNOLOGIES RECEIVES 510(k) CLEARANCE FOR PORTFOLIO OF SMALLER DIAMETER CELLVIZIO® MINIPROBES
Mauna Kea Technologies, leader in the endomicroscopy market and developer of Cellvizio®, the world’s smallest microscope, announced today that the U.S. Food and Drug Administration (FDA) has cleared a portfolio of smaller Cellvizio Miniprobes. Download the PDF
16/05/2012
-
MAUNA KEA TECHNOLOGIES ANNOUNCES HIGHLIGHTS OF 4TH ANNUAL INTERNATIONAL CONFERENCE OF CELLVIZIO® USERS (ICCU)
Over 120 international experts in endoscopy gathered in Rome to discuss use of Cellvizio to improve patient outcomes in digestive, respiratory disease and new indications. Download the PDF
14/05/2012
-
Mauna Kea Technologies Reports 155% First Quarter Sales Growth
Mauna Kea Technologies reported a 155% growth in sales for the first fiscal quarter, ended March 31, 2012 which drove the company’s overall sales for the period to €1.61 million, from €631,000 in the same period last year. Download the PDF
18/04/2012
-
Mauna Kea Technologies Appoints Gilles Brisson Chairman of the Board
Mauna Kea Technologies today announced that the company's Board of Directors appointed new board member Gilles Brisson to the role of Chairman of the Board. Download the PDF
10/04/2012
-
Mauna Kea Technologies Announces Full Year 2011 Financial Results
Sales of Cellvizio® systems and probes to hospitals grew +71%; gross margin reaches record high 68% of sales; cash and cash equivalents of €51 million at Dec. 31, 2011. Download the PDF
04/04/2012
-
MAUNA KEA TECHNOLOGIES APPOINTS MEDTECH EXPERT TO TOP SALES POSITION IN EMEA REGION
Mauna Kea Technologies announced today the appointment of industry veteran Georges Tabary as Vice President of Sales for the Europe, Middle East, and Africa (EMEA) region. Tabary will focus on structuring an elite sales force and implementing the company's sales strategy for its flagship Cellvizio® products in the EMEA region. Download the PDF
27/03/2012
-
MAUNA KEA TECHNOLOGIES’ CELLVIZIO® IS APPROVED FOR CATEGORY I CPT® CODES
Cellvizio® approved for Category I CPT Codes, facilitating reimbursement process in the United States. Download the PDF
13/03/2012
-
PERSEE PROJECT SUCCESSFULLY MEETS KEY MILESTONE, MAUNA KEA TECHNOLOGIES OBTAINS €1.7 MILLION IN FUNDING FROM OSEO
Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the endomicroscopy market, announced today that PERSEE, the consortium headed by Mauna Kea Technologies, has met a major milestone in its development and has obtained the second installment in funding from OSEO, a public sector institution dedicated to economic development in France. Download the PDF
08/02/2012
-
14/05/2012
30 Cellvizio abstracts accepted at DDW 2012
30 Cellvizio abstracts have been accepted at this year's Digestive Disease Week in San Diego, CA , May 19-22, 2012.more
-
09/05/2012
Mauna Kea Donates $100,000 to ASGE's Training Center
The American Society for Gastrointestinal Endoscopy (ASGE) Foundation has received a donation of $100,000 from Mauna Kea Technologies to ASGE’s IT&T Capital Campaign, a fundraising project to construct a new facility that will provide cutting-edge technology and training to gastroenterology professionals. The donation will be made over five years.more
See all news
-
14/06/2012
Cellvizio Live Show at IMAGE, Humanitas Hospital, Milan, Italy
Cellvizio will be showcased at IMAGE: The 2nd International Live Endoscopy Course, June 14 - 16 at Humanitas Hospital, Milan, Italy.
See all events
-
11/04/2012
Cellvizio News, April 2012
We are gearing up for the 4th Annual International Conference of Cellvizio Users (ICCU) being held on April 13th-15th in Rome, Italy.more
See all newsletters
-
03/05/2012
Cellvizio GI Workshop in Irvine, CA, USA
Acquire a basic understanding of how the Cellvizio system works, and learn how to interpret Cellvizio images of the esophagus, bile duct and colon. Live cases will be observed and the latest clinical data and case studies will be analyzed.
See all training opportunities
